D-Index & Metrics Best Publications

Ziyad M. Hijazi

Cornell University
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 71 Citations 21,752 349 World Ranking 16792 National Ranking 8535

Overview

What is he best known for?

The fields of study Ziyad M. Hijazi is best known for:

Warfarin
Rubella
Measles vaccine

Conventional PCI, Acute coronary syndrome and Percutaneous coronary intervention are the two main areas of interest in his Myocardial infarction studies. His research on Conventional PCI often connects related topics like Myocardial infarction. He integrates Acute coronary syndrome with Atrial fibrillation in his study. He frequently studies issues relating to Vitamin K antagonist and Atrial fibrillation. His Percutaneous coronary intervention study frequently links to other fields, such as Internal medicine. Much of his study explores Internal medicine relationship to Aspirin. He integrates several fields in his works, including Aspirin and Warfarin. He merges many fields, such as Warfarin and Antithrombotic, in his writings. His study on Antithrombotic is mostly dedicated to connecting different topics, such as Cardiology.

His most cited work include:

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation (705 citations)
GEOGRAPHIC VARIATION IN INFANT LOSS OF MATERNAL MEASLES ANTIBODY AND IN PREVALENCE OF RUBELLA ANTIBODY (86 citations)
Asthma in the desert: spectrum of the sensitizing aeroallergens (84 citations)

What are the main themes of his work throughout his whole career to date

Internal medicine combines with fields such as Pediatrics, Gastroenterology, Surgery and Cardiology in his investigation. His work blends Surgery and Internal medicine studies together. Immunology and Sensitization are commonly linked in his work. His Sensitization study frequently links to adjacent areas such as Immunology. In his works, Ziyad M. Hijazi conducts interdisciplinary research on Asthma and Allergy. Ziyad M. Hijazi connects Allergy with Atopy in his research. He performs integrative study on Atopy and Asthma. Ziyad M. Hijazi undertakes multidisciplinary studies into Antibody and Gene in his work. Ziyad M. Hijazi combines Gene and Antibody in his research.

Ziyad M. Hijazi most often published in these fields:

Internal medicine (66.67%)
Immunology (61.11%)
Asthma (55.56%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease)

Carole A. Warnes;Roberta G. Williams;Thomas M. Bashore;John S. Child.
Circulation (2008)

2966 Citations

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease

Carole A. Warnes;Roberta G. Williams;Thomas M. Bashore;John S. Child.
Journal of the American College of Cardiology (2008)

1578 Citations

Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial.

Zhong-Dong Du;Ziyad M Hijazi;Charles S Kleinman;Norman H Silverman.
Journal of the American College of Cardiology (2002)

1228 Citations

Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease A Scientific Statement From the American Heart Association

Timothy F. Feltes;Emile Bacha;Robert H. Beekman;John P. Cheatham.
Circulation (2011)

722 Citations

Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk

Zahid Amin;Ziyad M. Hijazi;John L. Bass;John P. Cheatham.
Catheterization and Cardiovascular Interventions (2004)

694 Citations

Transcatheter closure of secundum atrial septal defects using the new self‐centering amplatzer septal occluder: Initial human experience

Jozef Masura;Pavol Gavora;Augustin Formanek;Ziyad M. Hijazi.
Catheterization and Cardiovascular Diagnosis (1997)

567 Citations

Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results.

Robert H. Pass;Ziyad Hijazi;Daphne T. Hsu;Veronica Lewis.
Journal of the American College of Cardiology (2004)

469 Citations

Catheter Closure of Moderate- to Large-Sized Patent Ductus Arteriosus Using the New Amplatzer Duct Occluder: Immediate and Short-Term Results

Jozef Masura;Kevin P. Walsh;Basil Thanopoulous;Chen Chan.
Journal of the American College of Cardiology (1998)

465 Citations

Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: Immediate and mid-term results of a U.S. registry

Ralf Holzer;David Balzer;Qi-Ling Cao;Ken Lock.
Journal of the American College of Cardiology (2004)

399 Citations

Results of anterograde transcatheter closure of patent ductus arteriosus using single or multiple gianturco coils

Ziyad M. Hijazi;Robert L. Geggel.
American Journal of Cardiology (1994)

332 Citations

If you think any of the details on this page are incorrect, let us know.